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Metabolism and Mutagenicity of Isoprene
by P. G. Gervasi* and V. Longo*
Liver microsomes ofvarious rodents (mouse, rat, rabbit, and hamster) metabolize isoprene (2-methyl-
1,3-butadiene) to the corresponding monoepoxides 3,4-epoxy-3-methyl-1-butene and 3,4-epoxy-
2-methyl-1-butene. 3,4-Epoxy-3-methyl-1-butene (half-life 85 min) was found to be the main metabolite,
although the stable 3,4-epoxy-2-methyl-1-butene was also formed (about 14-25% with respect to the main
epoxide). Thekineticconstants(KmandVmn)fortheformation ofthe majorepoxidicmetaboliteofisoprene
were determined by gas-liquid chromatography. The minor epoxide was further epoxidized to the isoprene
dioxide by the microsomes ofall rodents studied. TheKm andVm.. were determined and phenobarbital was
found to be a good inducer for this epoxidation in all species. The mutagenic activity, using Salmonella
typhimurium, and the chemical reactivity (alkylating power and half-life) of the epoxide metabolites of
isoprene were investigated and compared to those ofother structurally related epoxides. Isoprene and the
monoepoxide intermediates of the isoprene biotransformation were not mutagenic in Salmonella ty-
phimurium. However, theisoprenedioxide(2-methyl-1,2,3,4-diepoxybutane) wasfoundtobemutagenicand
have alkylating power towards nicotinamide, similar to the structurally corresponding 1,2,3,4-diepoxy-
butane. Inconclusion, themetabolismofisoprenedoesnotleadtotheformationofmutagenic monoepoxide
(in contrast to butadiene) butthe formation ofmutagenic and presumably carcinogenic isoprenediepoxide
is possible, thereby a genotoxic effect of isoprene in rodents or other species cannot be ruled out.
Introduction
Isoprene (2-methyl-1,3-butadiene), an important
monomer used extensively in industry and largely de-
rived from petroleum cracking, is also the monomeric
unit of naturally occurring terpenes. It is also a spon-
taneousproduct ofemissionfrom manyplantspecies (1).
This paper presents our study results on the in vitro
biotransformation of isoprene by hepatic subcellular
fractions from various rodent species. Additionally, mu-
tagenicity and chemical reactivity of epoxidic inter-
mediates of isoprene metabolism are reported.
While the results of these biochemical and genetic
observations in rodents may not be directly related to
the consequences ofhuman occupational exposure, it is
hoped that they will provide some indication for future
epidemiological and industrial hygiene investigations.
Metabolism
Isoprene is readily metabolized, at least in small con-
centrations, in rats and in mice (1,2) and it is partially
converted into polar epoxidic metabolites. In our earlier
studies, we found that the biotransformation ofisoprene
involves microsomal P-450-dependent monooxygenases
(3,4).
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Isoprene binds to the active site ofcytochrome P-450
of microsomes from liver of rat, mouse, rabbit, and
hamster resulting in Type I difference spectra showing
similar Ks and AAmax. In addition, in microsomes ofall
rodents, differentformsofP-450appeartobindisoprene
to different extents, exhibiting two Ks values and two
AAmax values in the double-reciprocal plot.
Figure 1 shows the pathway of oxidative isoprene
metabolism by hepatic microsomes as determined by
gas-liquid chromatography (GLC) (3). Isoprene mono-
epoxides and the corresponding DIOL I and DIOL II
were produced as metabolites of isoprene in the pres-
ence of 02 and the NADPH-generating system. The
classical inhibitors of P-450, metyrapone, SKF 525-A,
and CO inhibit the metabolism ofisoprene. In all cases
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FIGURE 1. Microsomal metabolic pathways of isoprene. Major and
minor metabolic pathways are indicated by thick and thin arrows,
respectively.GERVASI AND LONGO
the oxidationresultedinEPOX-I andthecorresponding
DIOL Iasthemajormetabolites. EPOX-II, whichorigi-
nates from the oxidation of the unsubstituted double
bond of isoprene, was formed in smaller amounts from
themicrosomesofalltherodentsexamined(rabbit, 14%;
hamster, 17%; mouse, 20%; rat, 25%) (4). Inall casesthe
methyl-substituted double bond ofisoprene is themajor
site forthe enzymic oxidation by P-450, but not the only
site. This findingis in contrast to the chemical oxidation
of isoprene by peroxyacids that is selective for the
methyl-substituted double bond.
Since EPOX-I was veryreactive towards water (half-
life 85 min), the isoprene monoepoxidase activity was
determined more conveniently by followingthe produc-
tionrateoftheDIOL Iafterthechemicaland/orenzymic
hydrolysis of EPOX-I. This oxidation by liver micro-
somes from all rodents examined was linear over 10min
with 2 mg/mL of microsomal protein, and it followed
Michaelis-Menten kinetics giving linear Lineweaver-
Burk plots. The apparent Km and Vmax are shown in
Table 1. The affinity constants did not differ signifi-
cantly; however, Vmax did vary between rats and mice
by almost one order ofmagnitude. In mice, neither the
PB nor 3-methylcholanthrene treatments were able to
induce the isoprene epoxidase activity.
Liver microsomes ofall animals studied were able to
further oxidize EPOX-II, but not EPOX-I, to isoprene
diepoxide. The hydrophilicity ofEPOX-I, in addition to
its high reactivity towards water and the conjugation of
the double bond with the oxirane ring, probably pre-
vents its epoxidation by P-450.
The epoxidation ofEPOX-II was NADPH and 02 de-
pendent, inhibited by CO, and followed Michaelis-
Mentenkinetics. Thekineticconstantsweredetermined
bymeasuringtheisoprenediepoxideproductionbyGLC
Table 1. Kinetic parameters for DIOL-I formation from isoprene
oxidation by various rodent microsomes.a
V.9
nmole Diol-I/
Rodent species, male Kin, mM mg protein x minb
Rat, Wistar 0.08 ± 0.05 0.24 ± 0.1
Rabbit, New Zealand 0.2 ± 0.1 0.66 ± 0.3
Hamster, Syrian golden 0.06 ± 0.04 1.20 ± 0.4a
Mouse, CD 1 0.09 ± 0.05 1.79 ± 0.5a
aValues are reported as an average + SD for three or more experi-
ments performed with different preparations ofhepatic microsomes.
bProtein concentrations was 2 mg/mL and incubation time was 10
min.
*Significantly different from rat microsomes, p < 0.01 Student's
t-test.
using microsomes from either untreated or pheno-
barbital (PB)-treated rodents (Table 2). Compared to
controls, PB increased the Vmax in all species examined,
particularly in rats and rabbits where Vmax was in-
creased about 10-fold. Besides the PB induction, an
important observation is that the rates ofisoprene die-
poxide formation were comparable to those ofisoprene
monoepoxidationwithmicrosomesofuntreatedrodents.
These findings show that the inducible formation ofthe
reactive isoprene diepoxide could be a relevant inter-
mediate step in mammalian isoprene metabolism.
Mutagenicity and Chemical Reactivity
Isoprene was not mutagenic in five strains ofSalmo-
nella typhimurium, even after metabolic activation
using rat-liver microsomes (5,6). The mutagenic activi-
ties ofisoprene epoxides and, forcomparison, butadiene
epoxides were tested with Salmonella typhimurium
strains TA98 and TA100 (7). All epoxides were assayed
with the standard-plate incorporation test, without
metabolic activation since they are direct-alkylating
compounds. Amongthe epoxide metabolites ofisoprene
only the diepoxide proved to be mutagenic in TA100
strain with a linear dose-effect relationship, while the
structurally related butadiene epoxides all showed mu-
tagenicactivities inTA100, in agreementwithpublished
data (8).
Tostudythe correlationbetweenmutagenic activities
ofoxiranesandtheirchemicalproperties, Table3shows:
the mutagenic activity of isoprene and butadiene ep-
oxides at 0.15 mM concentrations, measured from the
linear part ofthe dose-effect relationship; the half-lives
ofepoxidesinTris-buffer, pH7.4, determinedby aGLC;
and the alkylation rates of epoxides towards nicotina-
mide, anucleophilic target (9). EPOX-I themainmetab-
olite ofisoprene, was neither mutagenic nor alkylating
although its reactivity towards water was high.
By contrast, the corresponding epoxide without the
methyl group in the oxirane ring, 1,2-epoxy-3-butene,
although lessreactive towards waterthan EPOX-I, was
an active alkylating agent and mutagenic to Salmonella.
A similar effect ofmethyl as asubstituent inthe oxirane
ring has been found for other compounds. a-Methyl
styrene oxide, 2-methyl propylene oxide, and 1,2-
epoxy-2-methylbutane did not show mutagenic activity
(10) while the corresponding styrene oxide, propylene
oxide and 1,2-epoxybutane were mutagenic and had
alkylating activity (7). The methyl substitution in the
oxirane ring causes a steric hindrance. Because of its
Table 2. Effect of PB pretreatment of rodents on the microsomal oxidation of EPOX-II.a
Hamster Rat Rabbit Mouse
Kinetic parameters Control PB Control PB Control PB Control PB
Km, mM 0.9 ± 0.2 1.9 ± 0.7 ND 0.6 ± 0.2 ND 5.9 ± 2.1 0.24 ± 0.030.29 ± 0.05
Vmax, nmolediepoxide/mg protein x min 1.5 ± 2.3 5.6 ± 1.2 0.3 ± 0.1 3.8 ± 1.3" 0.2 ± 0.1 4.21 + 1.5 1.7 ± 0.4 5.1 ± 1.2*
aValues are means ± SD of three experiments performed with different preparations of hepatic microsomes.
'Protein concentration was 2 mg/mL and incubation time was 15 min.
*Significantly different from control microsomes ofthe corresponding animal species (p < 0.01, Student's t-test).
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Table 3. Mutagenicity (Ames test S. typhimurium TA 100)
alkylation rates (nicotinamide-test) and half-life of epoxides.
Alkylation rate, Mutagenicity, Half-life,
Compound fluorescence/hr revertants/plate* hr
\
CH,-C-CH-CH2
CH, 15 0 1.25
a. 3,4.epoxy-3-methyI-1-bule
/\
CHa-CH-C-CH2
b. 3.4.epozy-2-methYl-l-buIO 35 0 7 3
/P\
CH2-C-CH2-CH3
C, I10 0 112 c. 1.2-epoxy.2-methylbutane1 1
/P\ A
CH,-C-CH-CH2
CH, 360 1700 4 6 d. 2-me1byI.l,2.3,4-diepoxYbU-8l 6 704
e. 1.2.cobexaae 30 153 128
/\ /\
CH2-CH-CH-CH,
f. 12.3.4i ybulan 400 1366 100
"\
CH,- CH-CH-CH2
g. 12.epoxy-3-bule 180 346 13.7
P\
CH,- CH-CH,-CH,
h. 12-tpoxybutane 150 257 156
* Histidine revertants induced by 15 mM epoxide
electron-donating action, the methyl group could effect
the mechanism ofnucleophilic substitution, shifting the
substitution mechanism towards an SN1 type. In such a
condition, thehighlypolarized carbonatom, partlyham-
pered by the methyl group, will react mainly with small
polar molecules such as water. The correlation between
mutagenicity and alkylating power for epoxides holds
whenthemechanismofalkylationisanSN2type, butnot
when it becomes mainly SN1. This correlation was
shown for the carbocationic intermediates ofethylating
or methylating mutagenic agents (11).
The lack of mutagenicity and alkylating abilities of
EPOX II could be explained bythe fact that the methyl
substitution on the double bond causes a steric effect
and, moreover, can counteract the oxirane destabiliza-
tion because ofthe resonance between double bond and
oxirane ring.
Isoprene diepoxide was found to have a half-life and
mutagenic and alkylating activities similar to those of
the structurally related butadiene diepoxide, a mu-
tagenic, clastogenic, and carcinogenic compound.
Conclusions
Isoprene metabolism showed the same pattern in all
rodent species studied; in contrast to the metabolism of
the analogs butadiene (12) or other conjugated olefins
(13), it did not result in mutagenic monoepoxide
intermediates.
The ratios between the isoprene monoepoxides
formed were similar in all rodents studied. Although
only 3,4-epoxy-2-methyl-1-butene, the monoepoxide
produced in small amount, was able to be further oxi-
dized by P-450-dependent monooxygenases to the mu-
tagenic isoprene diepoxide, apossible mutagenic and/or
carcinogenic potential of isoprene still remains. How-
ever, investigators need to clarify whether a similar
metabolic pattern occurs in extrahepatic rodent tissues
and, more important, in human tissues and in other
living species.
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